Collagen Solutions has provided a strong trading update ahead of its results for the six months to 30 Sept 2019. Revenues are expected to grow by 14.4% to £2.23m, driven in particular by continuing momentum in their newly established tissue business. Business development remains strong with additional new contracts and customers acquired during the period. With regards to the proprietary product, ChondroMimetic, the company remains engaged in the CE notification process. We remain confident in o ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Collagen Solutions Plc - Strong update
- Published:
22 Oct 2019 -
Author:
Chris Donnellan -
Pages:
6
Collagen Solutions has provided a strong trading update ahead of its results for the six months to 30 Sept 2019. Revenues are expected to grow by 14.4% to £2.23m, driven in particular by continuing momentum in their newly established tissue business. Business development remains strong with additional new contracts and customers acquired during the period. With regards to the proprietary product, ChondroMimetic, the company remains engaged in the CE notification process. We remain confident in o ....